BSX sees approval in Europe, Asia for new heart device
Boston Scientific Corp. (NYSE: BSX) has received approval to market an upgraded version of its implantable defibrillation lead device in Europe and Asia.
Boston Scientific Corp. (NYSE: BSX) has received approval to market an upgraded version of its implantable defibrillation lead device in Europe and Asia.